| Literature DB >> 30940876 |
Leonard R Pelgrom1, Thiago A Patente1, Alexey Sergushichev2, Ekaterina Esaulova3, Frank Otto1, Arifa Ozir-Fazalalikhan1, Hendrik J P van der Zande1, Alwin J van der Ham1, Stefan van der Stel1, Maxim N Artyomov3, Bart Everts4.
Abstract
Liver Kinase B1 (LKB1) plays a key role in cellular metabolism by controlling AMPK activation. However, its function in dendritic cell (DC) biology has not been addressed. Here, we find that LKB1 functions as a critical brake on DC immunogenicity, and when lost, leads to reduced mitochondrial fitness and increased maturation, migration, and T cell priming of peripheral DCs. Concurrently, loss of LKB1 in DCs enhances their capacity to promote output of regulatory T cells (Tregs) from the thymus, which dominates the outcome of peripheral immune responses, as suggested by increased resistance to asthma and higher susceptibility to cancer in CD11cΔLKB1 mice. Mechanistically, we find that loss of LKB1 specifically primes thymic CD11b+ DCs to facilitate thymic Treg development and expansion, which is independent from AMPK signalling, but dependent on mTOR and enhanced phospholipase C β1-driven CD86 expression. Together, our results identify LKB1 as a critical regulator of DC-driven effector T cell and Treg responses both in the periphery and the thymus.Entities:
Mesh:
Substances:
Year: 2019 PMID: 30940876 PMCID: PMC6796856 DOI: 10.1038/s41422-019-0161-8
Source DB: PubMed Journal: Cell Res ISSN: 1001-0602 Impact factor: 25.617